Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
Transcranial Direct Current Stimulation and Mirror Therapy in Neuropathic Pain
1 other identifier
interventional
12
1 country
1
Brief Summary
Traumatic injuries of the brachial plexus cause sufficient weakness to affect the individual in its various aspects, limiting the execution of Activities of Daily Living, leading to highly disabling, and often definitive, clinical conditions with serious socioeconomic consequences. It causes motor, sensory and autonomic deficits, directly compromising the quality of life and functional performance of these individuals. It is a complex condition, whose recovery is usually slow and costly, in addition to often requiring surgery and rehabilitation. Among the therapeutic possibilities, the non-invasive neuromodulation techniques stand out, especially the Transcranial Direct Current Stimulation (ETCC) and the Mirror Therapy (ET). In this context, the present study aims to analyze the effectiveness of the ETCC technique combined with ET in the treatment of patients with pain due to trauma to the brachial plexus, investigating the degree of improvement in pain intensity, functionality, quality of life and mood of these patients, comparing the onset with immediately after applying the techniques.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable chronic-pain
Started Sep 2019
Shorter than P25 for not_applicable chronic-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 8, 2019
CompletedFirst Submitted
Initial submission to the registry
February 23, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 28, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 28, 2020
CompletedFirst Posted
Study publicly available on registry
May 12, 2020
CompletedMay 12, 2020
May 1, 2020
6 months
February 23, 2020
May 11, 2020
Conditions
Outcome Measures
Primary Outcomes (3)
Change in pain intensity
Visual analog scale (VAS) - One-dimensional instrument for assessing pain intensity. It is a line with the ends numbered 0-10. At one end line is marked "no pain" and on the other "worse pain imaginable".
Baseline and after 4 weeks
Changes in pain interference in activities of daily living
1 - Brief Pain Inventory - reduced form (Brief Pain Inventory - BPI): Multidimensional instrument, which makes use of a scale of 0-10 to graduate the following items: intensity, pain interference on ability for walking, daily activities of the patient, at work, social activities, mood and sleep.
Baseline and after 4 weeks
Change in pain characteristics
2 - McGill Pain Questionnaire - MPQ): The descriptors are divided into four groups: sensory discriminative, motivational affective, cognitive evaluative, and miscellaneous. The numerical index of descriptors is the number of words chosen by the patient to characterize your pain, being at most a word of each subgroup with a maximum value of 20. The pain index is calculated by adding the values of intensity of each descriptor (0-5), having this maximum 78.
Baseline and after 4 weeks
Secondary Outcomes (4)
Quality of life (SF-36)
Baseline and after 4 weeks
Functionality
Baseline and after 4 weeks
Depression
Baseline and after 4 weeks
Anxiety
Baseline and after 4 weeks
Study Arms (2)
ETCC Active associated with Mirror Therapy (TE)
ACTIVE COMPARATORThe study will consist of 12 sessions, being carried out over a period of 1 month, with 3 weekly sessions on consecutive days, where each patient will receive ETCC for 30 minutes concomitantly with ET. Outcome assessments will be performed before the beginning of the protocol on the base (T0) and immediately after the end of the 12 sessions (T1).
ETCC simulated associated with Mirror Therapy (TE)
SHAM COMPARATORThe study will consist of 12 sessions, being carried out over a period of 1 month, with 3 weekly sessions on consecutive days, where each patient will receive ETCC for 30 minutes concomitantly with ET. Outcome assessments will be performed before the beginning of the protocol on the base (T0) and immediately after the end of the 12 sessions (T1).
Interventions
The study will consist of 12 sessions, carried out over a period of 1 month, with 3 weekly sessions on consecutive days, where each patient will receive ETCC for 30 minutes concomitantly with ET. Outcome assessments will be performed before the beginning of the protocol on the base (T0) and immediately after the end of the 12 sessions (T1).
Eligibility Criteria
You may qualify if:
- Age over 18 years;
- Score of 4 to 10 points on the Visual Analogue Scale;
- Persistent pain and refractory to clinical treatment for at least 3 months;
- Appropriate pharmacological treatment for pain for at least 1 month before the start of the study.
You may not qualify if:
- Patients with other neurological diseases;
- Past history of substance abuse;
- Contraindications for ETCC.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Suellen Marinho Andrade
João Pessoa, Paraíba, Brazil
Related Publications (1)
Ferreira CM, de Carvalho CD, Gomes R, Bonifacio de Assis ED, Andrade SM. Transcranial Direct Current Stimulation and Mirror Therapy for Neuropathic Pain After Brachial Plexus Avulsion: A Randomized, Double-Blind, Controlled Pilot Study. Front Neurol. 2020 Dec 11;11:568261. doi: 10.3389/fneur.2020.568261. eCollection 2020.
PMID: 33362687DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Suellen Andrade
Federal University of Paraiba
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator and Professor
Study Record Dates
First Submitted
February 23, 2020
First Posted
May 12, 2020
Study Start
September 8, 2019
Primary Completion
February 28, 2020
Study Completion
February 28, 2020
Last Updated
May 12, 2020
Record last verified: 2020-05